IPSC Long Put Strategy

IPSC (Century Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma. Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.

IPSC (Century Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $197.4M, a beta of 1.56 versus the broader market, a 52-week range of 0.435-3.04, average daily share volume of 1.2M, a public-listing history dating back to 2021, approximately 140 full-time employees. These structural characteristics shape how IPSC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.56 indicates IPSC has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long put on IPSC?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current IPSC snapshot

As of May 15, 2026, spot at $2.33, ATM IV 50.00%, IV rank 6.11%, expected move 14.33%. The long put on IPSC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long put structure on IPSC specifically: IPSC IV at 50.00% is on the cheap side of its 1-year range, which favors premium-buying structures like a IPSC long put, with a market-implied 1-standard-deviation move of approximately 14.33% (roughly $0.33 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IPSC expiries trade a higher absolute premium for lower per-day decay. Position sizing on IPSC should anchor to the underlying notional of $2.33 per share and to the trader's directional view on IPSC stock.

IPSC long put setup

The IPSC long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IPSC near $2.33, the first option leg uses a $2.33 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IPSC chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IPSC shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$2.33N/A

IPSC long put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

IPSC long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on IPSC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long put on IPSC

Long puts on IPSC hedge an existing long IPSC stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying IPSC exposure being hedged.

IPSC thesis for this long put

The market-implied 1-standard-deviation range for IPSC extends from approximately $2.00 on the downside to $2.66 on the upside. A IPSC long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long IPSC position with one put per 100 shares held. Current IPSC IV rank near 6.11% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IPSC at 50.00%. As a Healthcare name, IPSC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IPSC-specific events.

IPSC long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IPSC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IPSC alongside the broader basket even when IPSC-specific fundamentals are unchanged. Long-premium structures like a long put on IPSC are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current IPSC chain quotes before placing a trade.

Frequently asked questions

What is a long put on IPSC?
A long put on IPSC is the long put strategy applied to IPSC (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With IPSC stock trading near $2.33, the strikes shown on this page are snapped to the nearest listed IPSC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are IPSC long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the IPSC long put priced from the end-of-day chain at a 30-day expiry (ATM IV 50.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a IPSC long put?
The breakeven for the IPSC long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IPSC market-implied 1-standard-deviation expected move is approximately 14.33%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on IPSC?
Long puts on IPSC hedge an existing long IPSC stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying IPSC exposure being hedged.
How does current IPSC implied volatility affect this long put?
IPSC ATM IV is at 50.00% with IV rank near 6.11%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related IPSC analysis